日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Europe

US buys up world stock of COVID-19 drug

By CHEN WEIHUA in Brussels | chinadaily.com.cn | Updated: 2020-07-02 03:02
Share
Share - WeChat
FILE PHOTO: A lab technicians holds the coronavirus disease (COVID-19) treatment drug "Remdesivir" at Eva Pharma Facility in Cairo, Egypt June 25, 2020. [Photo/Agencies]

The World Health Organization on Wednesday voiced concerns over news reports that the United States government has bought almost all the stocks of key COVID-19 drug remdesivir.

US President Donald Trump's administration has bought up virtually all the stocks for the next three months of one of the two drugs proven to work against COVID-19, causing alarm among experts and campaigners, the Guardian newspaper reported.

Mike Ryan, executive director of WHO Health Emergencies Program, said the WHO is aware of media reports about procurement of the remdesivir stock and is working with colleagues and partners in the COVID-19 Tools Accelerator program to verify the reports.

"Obviously there are many people around the world who are very sick with this disease. And we want to ensure that everybody has access to the necessary life-saving interventions," Ryan told a virtual news briefing from Geneva.

He reiterated the WHO's pledge, saying "we are fully committed as an organization with our partners to equitable access to lifesaving interventions".

When asked if the US had made a pledge to make sure COVID-19 vaccines are global public goods, Ryan said it was a question for the US government.

China and several other countries have pledged to make vaccines global public goods once their development proves successful.

US President Donald Trump announced in late May to terminate relations with the WHO and also cut US funding to the global health body.

Talking about the current relationship between WHO and the US, Ryan said he can only speak to the technical collaboration. "Certainly we are grateful to continue to engage with our technical counterparts in the United States in all matters related to science and public health," he said.

"We are in contact. We are still discussing. There are collaboration on many issues," said WHO Director-General Tedros Adhanom Ghebreyesus.

Remdesivir, the first drug approved by licensing authorities in the US to treat COVID-19, is made by Gilead and has been shown to help people recover faster from the pandemic.

The first 140,000 doses, supplied to drug trials around the world, have been used up. The US government has now bought more than 500,000 doses, which is all of Gilead's production for July and 90 percent of August and September.

"President Trump has struck an amazing deal to ensure Americans have access to the first authorized therapeutic for COVID-19," said US Health and Human Services Secretary Alex Azar.

"To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people," he said.

The drug is under patent to Gilead, which means no other company in wealthy countries can make it. The cost is around $3,200 per treatment of six doses, according to the US government statement.

COVID-19 cases in the US are spiraling out of control. The US has recorded more than 1.5 million cases and 126,000 deaths from COVID-19, the highest in the world. On Tuesday, it reported 41,008 new cases and 885 deaths, according to WHO.

The Guardian contributed to this story.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 色男人综合 | 日本激情网 | 毛片a级| 特黄特色的免费大片看看 | 欧美日韩在线观看免费 | 欧美三级成版人版在线观看 | 尤物国产在线精品福利一区 | 毛片国产 | 免费看的黄网站 | 中文二区 | 午夜性刺激小说 | 欧美激情在线精品一区二区 | 亚洲国产精品视频一区 | 国产精品蜜臂在线观看 | 国产美女一区二区 | 国产全肉乱妇杂乱视频 | 久久一区二区三区四区 | 精品福利在线视频 | 日本人成年视频在线观看 | 日韩欧美高清 | 欧美日韩一区二区中文字幕视频 | 韩日在线视频 | 毛片链接 | 亚洲 欧美 日韩 综合aⅴ视频 | 高清国产一区二区三区四区五区 | 欧美精品无需播放器在线观看 | 欧美黑人玩白人巨大极品 | 天天做天天欢天天爽 | 亚洲电影在线观看 | 国产成人精品高清在线观看99 | 一级黄色绿像片 | 亚洲国产99在线精品一区二区 | 日韩精品一区二区三区视频播放 | 欧洲精品视频完整版在线 | 国产小视频免费在线观看 | 91麻豆国产极品在线观看洋子 | 丁香花成人另类小说 | 一级视频在线免费观看 | 美国黄色毛片女人性生活片 | 91青青青青青爽在线 | 激情av在线 |